Inhibikase Therapeutics, Inc. — SBIR/STTR Competitive Profile

Aggregate SBIR/STTR award history for Inhibikase Therapeutics, Inc., built entirely from public federal award records. Free competitive intelligence — no login required.

Phase mix

Funding agencies

Awards by year

Places of performance

Firms like Inhibikase Therapeutics, Inc.

See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.

Recent awards

AwardAgencyAmountProgramStart
1R43NS120403-01A1 Department of Health and Human Services $385,888 SBIR · Phase I 2021-09-23
2R44CA224731-02 Department of Health and Human Services $2,002,000 SBIR · Phase II 2018-09-17
1R43CA224731-01 Department of Health and Human Services $284,778 SBIR · Phase I 2017-09-06
1R44NS103695-01 Department of Health and Human Services $3,108,583 SBIR · Phase II 2017-09-01
2R44AI103982-04 Department of Health and Human Services $1,787,776 SBIR · Phase II 2016-06-01
1R43AI103982-01A1 Department of Health and Human Services $300,000 SBIR · Phase I

Frequently asked questions

How many SBIR/STTR awards has Inhibikase Therapeutics, Inc. won?

Inhibikase Therapeutics, Inc. has won 6 SBIR/STTR awards worth $7,869,025 in the public federal award records SBIR Signal tracks, including 3 Phase I and 3 Phase II award(s).

Which agencies fund Inhibikase Therapeutics, Inc.?

Inhibikase Therapeutics, Inc.'s awards come from 1 agency on record; its top funder is Department of Health and Human Services.

What technology areas does Inhibikase Therapeutics, Inc. work in?

Based on its award history, Inhibikase Therapeutics, Inc. works in a range of technology areas.

How do I find firms similar to Inhibikase Therapeutics, Inc.?

Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.